Analysts Set Ryan Specialty Holdings, Inc. (NYSE:RYAN) Target Price at $75.67

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) have been given an average recommendation of “Hold” by the thirteen ratings firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $75.67.

A number of equities analysts have weighed in on the company. TD Cowen assumed coverage on Ryan Specialty in a research report on Thursday, April 10th. They issued a “buy” rating and a $89.00 target price for the company. Keefe, Bruyette & Woods decreased their target price on Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating for the company in a research report on Wednesday, April 9th. UBS Group boosted their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Wells Fargo & Company decreased their target price on Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. Finally, Barclays reduced their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a research report on Friday, April 11th.

Ryan Specialty Trading Up 1.7 %

RYAN opened at $65.41 on Monday. The stock has a market cap of $17.13 billion, a PE ratio of 94.80, a PEG ratio of 1.19 and a beta of 0.66. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The business has a 50 day moving average of $70.26 and a 200-day moving average of $68.83. Ryan Specialty has a 52 week low of $48.85 and a 52 week high of $77.16.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. Equities research analysts predict that Ryan Specialty will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.73%. Ryan Specialty’s payout ratio is 69.57%.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its stake in Ryan Specialty by 107.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after purchasing an additional 238,064 shares during the period. Bar Harbor Wealth Management boosted its stake in Ryan Specialty by 5.9% in the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock worth $10,835,000 after purchasing an additional 9,482 shares during the period. Barclays PLC boosted its stake in Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after purchasing an additional 17,267 shares during the period. GAMMA Investing LLC boosted its stake in Ryan Specialty by 38.1% in the 4th quarter. GAMMA Investing LLC now owns 1,725 shares of the company’s stock worth $111,000 after purchasing an additional 476 shares during the period. Finally, Embree Financial Group boosted its position in shares of Ryan Specialty by 64.1% during the 4th quarter. Embree Financial Group now owns 83,212 shares of the company’s stock valued at $5,339,000 after acquiring an additional 32,500 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.